Scienture Holdings, Inc. current report, 22 September 2014

Business Context and Reporting Period

This Form 8-K was filed by Trxade Group, Inc. (noting a discrepancy with the metadata request for "Scienture Holdings, Inc.") on September 25, 2014, reporting events occurring on September 21, 2014. The filing details a private placement transaction involving the issuance of equity securities to raise capital.

Key Financial Metrics and Transaction Details

  • Capital Raised: $1,100,000 in aggregate cash purchase price.
  • Shares Issued: 733,333 shares of Common Stock ($0.00001 par value).
  • Warrants Issued: Warrants to purchase 183,333 shares of Common Stock.
  • Price Per Share: $1.25 net price per share.
  • Warrant Terms: Five-year term with an exercise price of $0.01 per share.
  • Registration Rights: Investors granted demand and piggyback registration rights.

Material Changes

The filing reports a material definitive agreement and unregistered sales of equity securities. The company expanded its capital base through the private placement, resulting in an immediate increase in outstanding common stock and potential future dilution via the attached warrants. No prior period financial data is provided in this specific filing for comparison.

Guidance, Outlook, and Risks

The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard securities law disclosures. The transaction was executed in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D. The securities are restricted and cannot be offered or sold in the United States absent registration or an applicable exemption.

Investor Verification Checklist

  • Verify the correct registrant name (Trxade Group, Inc. vs. Scientificure Holdings, Inc.) to ensure the filing applies to the intended entity.
  • Review the full text of the Subscription Agreement (Exhibit 10.1) and Warrant Agreement (Exhibit 10.2) for specific covenants and conditions.
  • Confirm the impact of the 733,333 new shares and 183,333 warrants on total shareholder dilution.
  • Check subsequent filings to determine if the registration rights were exercised or if the warrants were converted.